CMA’s Final Decision on UK Veterinary Services: A Necessary Reset or Overreach?
Today’s announcement from the UK’s Competition and Markets Authority (CMA) marks one of the most significant regulatory interventions our profession has seen in a generation. After more than two years of scrutiny, the CMA has formally concluded that the veterinary sector is not functioning competitively enough—and, crucially, that pet owners are being disadvantaged as a result.
As someone who speaks daily with veterinary surgeons across the UK, I think it’s important we step back from the headlines and look at what this actually means—for clients, for practices, and for you as a clinician building your career.
What Has the CMA Actually Decided?
At its core, the CMA’s findings centre on a lack of transparency and weakened competition. The regulator concluded that many pet owners are “in the dark” when it comes to pricing, ownership structures, and treatment choices—factors which, in turn, contribute to rising costs.
The remedies introduced are wide-ranging and, importantly, legally binding. The most notable include:
Mandatory price transparency: Practices must publish clear, standardised price lists.
Prescription fee caps: £21 for the first medication and £12.50 for additional items.
Clear disclosure of ownership: Corporate groups must make branding more explicit.
Written estimates for higher-cost treatments (typically over £500).
Development of comparison tools to help clients navigate providers.
These changes will begin rolling out later this year, with full implementation expected by September 2026.
The CaseFor the CMA’s Intervention
From a consumer perspective, the CMA’s case is compelling.
Veterinary costs have risen significantly—reportedly at around twice the rate of inflation in recent years.
At the same time, the growth of corporate ownership has made it harder for clients to understand who they are dealing with and how prices are set.
Greater transparency should:
Empower clients to make informed decisions
Reduce the sense of “bill shock”
Potentially ease the pressure on complaints and reputational scrutiny
Even the profession’s own representative body has broadly welcomed the direction of travel, particularly around improving transparency and client choice.
From where I sit, many vets—especially those earlier in their careers—have found the public narrative around pricing deeply uncomfortable. Anything that rebuilds trust between vets and clients has value.
The CaseAgainst: Where Concerns Remain
That said, it would be disingenuous to suggest the sector is universally supportive.
A number of concerns are being raised quietly—but seriously—across the industry:
1. Oversimplification of Clinical Work
Veterinary medicine is not a commodity. Pricing is influenced by complexity, equipment, staffing, and clinical judgement. There is a real concern that standardised price lists may unintentionally:
Encourage price-based competition over quality
Reduce flexibility in complex or evolving cases
2. Pressure on Practice Viability
Independent practices, in particular, may feel the administrative and financial burden more acutely. While the CMA has softened some earlier proposals (for example, increasing the prescription cap and allowing longer implementation timelines), margins remain tight.
3. Impact on Investment and Innovation
Corporate groups have played a significant role in funding advanced diagnostics, facilities, and referral services. There is a question—still unanswered—about whether increased regulation could dampen future investment.
4. Professional Morale
After a prolonged period of scrutiny, many veterinary teams feel they have been portrayed unfairly. It is notable that the CMA itself acknowledged the profession’s “professionalism, compassion, and commitment to animal welfare” in its final report.
What This Means for Veterinary Surgeons
If you are a veterinary surgeon—particularly in that 3–10 years qualified bracket—this decision will shape your working environment in subtle but important ways.
In the short term:
Expectmore client conversations around cost and transparency
Greater emphasis oncommunication skills alongside clinical ability
Potential operational changes within your practice
In the medium term:
Practices thatdifferentiate on quality of care and client experience are likely to thrive
There may beincreased movement between independent and corporate settings, as each adapts differently
New roles may emerge aroundclinical governance, pricing strategy, and client communication
A Balanced View: Reform, Not Revolution
In my view, today’s decision is not a dismantling of the veterinary sector—but itis a reset.
The CMA has stopped short of more radical structural interventions. Instead, it has focused on transparency and informed choice. That feels deliberate: a recognition that while the market has flaws, the underlying clinical standards and professional integrity remain strong.
For veterinary surgeons, this is not about fearing change—but understanding it.
The practices that succeed over the next 3–5 years will be those that combine:
Clinical excellence
Clear communication
Thoughtful, transparent pricing
And for you individually, it creates an opportunity to align yourself with employers who genuinely invest in all three.